GlassScriptPhysician profile
Indira Dhandapani
NPI 1104246248
$898.61
in general payments reported to CMS, 2019-2025
15 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $46.24 · 2021: $24.18 · 2022: $65.35 · 2023: $22.69 · 2024: $261 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $214.97 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $141.01 | 2024 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $72.39 | 2019-2024 | Veozah |
| Biogen, INC. | $71.69 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $66.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.33 | 2019-2022 | |
| Coopersurgical, INC. | $52.42 | 2022-2025 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $44.35 | 2024-2025 | |
| Allergan, INC. | $39.61 | 2019 | |
| Millicent US INC | $38.34 | 2025 | Intrarosa, Femring, Femlyv |
| Sage Therapeutics, LLC | $21.15 | 2024 | |
| Duchesnay USA Incorporated | $18.91 | 2019 | |
| Pfizer INC. | $18.73 | 2024 | |
| Merck Sharp & Dohme LLC | $17.04 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indira Dhandapani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.